106 related articles for article (PubMed ID: 637676)
1. [Pharmacokinetic study of intravenous furosemide in nephrotic syndrome in children].
Lenoir G; Halter D; Seligman R; Dreuz C
Arch Fr Pediatr; 1978 Feb; 35(2):187-97. PubMed ID: 637676
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of furosemide in children with nephrotic syndrome.
González-Martín G; Bravo I; Ibarra N; Arancibia A
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):598-601. PubMed ID: 6668097
[TBL] [Abstract][Full Text] [Related]
3. Urinary elimination kinetics and diuretic effect of intravenous furosemide in nephrotic children.
Prandota J
Dev Pharmacol Ther; 1982; 5(1-2):98-108. PubMed ID: 7151641
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of furosemide urinary elimination by nephrotic children.
Prandota J
Pediatr Res; 1983 Feb; 17(2):141-7. PubMed ID: 6828331
[TBL] [Abstract][Full Text] [Related]
5. [The effect of albumin and furosemide administration in children with primary nephrotic syndrome (author's transl)].
Rego Filho Ede A; Casoni W
Rev Bras Pesqui Med Biol; 1977; 10(5):299-304. PubMed ID: 594431
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of albumin and diuretic therapy in children with nephrotic syndrome.
Haws RM; Baum M
Pediatrics; 1993 Jun; 91(6):1142-6. PubMed ID: 8502517
[TBL] [Abstract][Full Text] [Related]
7. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
8. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
[TBL] [Abstract][Full Text] [Related]
9. [Relation between the diuretic effect of furosemide, its rate of urinary excretion, urinary concentration and the amount excreted in the urine in children with normal renal function].
Prandota J
Pediatr Pol; 1982; 57(9):703-10. PubMed ID: 7170149
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of high dose furosemide in patients with chronic renal failure or nephrotic syndrome.
Kühnel HJ; Günther K; Stein G; Hoffmann-Traeger A
Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):616-21. PubMed ID: 3429064
[TBL] [Abstract][Full Text] [Related]
11. Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome.
Takamura N; Maruyama T; Chosa E; Kawai K; Tsutsumi Y; Uryu Y; Yamasaki K; Deguchi T; Otagiri M
Drug Metab Dispos; 2005 Apr; 33(4):596-602. PubMed ID: 15640375
[TBL] [Abstract][Full Text] [Related]
12. Muzolimine vs. furosemide in nephrotic syndrome: further support of different carrier(s) operating for enteral absorption.
Bazzato G; Coli U; Landini S; Fracasso A; Righetto F; Scanferla F; Forte M; Morachiello P
Z Kardiol; 1985; 74 Suppl 2():92-5. PubMed ID: 4002811
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics of orally administered furosemide in children with nephrotic syndrome].
Prandota J
Pediatr Pol; 1982; 57(9):711-8. PubMed ID: 7170150
[No Abstract] [Full Text] [Related]
14. Effectiveness of bumetanide in nephrotic syndrome: a double-blind crossover study with furosemide.
Lau K; DeFronzo R; Morrison G; Rascoff J; Goldberg M; Agus ZS
J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):489-97. PubMed ID: 789411
[TBL] [Abstract][Full Text] [Related]
15. Coadministration of albumin and furosemide in patients with the nephrotic syndrome.
Fliser D; Zurbrüggen I; Mutschler E; Bischoff I; Nussberger J; Franek E; Ritz E
Kidney Int; 1999 Feb; 55(2):629-34. PubMed ID: 9987087
[TBL] [Abstract][Full Text] [Related]
16. Determinants of furosemide delivery to its site of action.
Sjöström PA; Kron BG; Odlind BG
Clin Nephrol; 1995 Jan; 43 Suppl 1():S38-41. PubMed ID: 7781204
[TBL] [Abstract][Full Text] [Related]
17. A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
Sagar S; Sharma BK; Sharma PL; Wahi PL
Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):473-8. PubMed ID: 6389378
[TBL] [Abstract][Full Text] [Related]
18. Co-administration of albumin-furosemide in patients with the nephrotic syndrome.
Ghafari A; Mehdizadeh A; Alavi-Darazam I; Rahimi E; Kargar C; Sepehrvand N
Saudi J Kidney Dis Transpl; 2011 May; 22(3):471-5. PubMed ID: 21566302
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of gentamicin in children with nephrotic syndrome.
González-Martin G; Bravo I; Vargas H; Arancibia A
Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):555-8. PubMed ID: 3781676
[TBL] [Abstract][Full Text] [Related]
20. [Atrial natriuretic peptide in children with nephrotic syndrome].
Jovanovitsh O; Popovitsh-Rolovitsh M; Radoshevitsh P; Stankovitsh R; Dujitsh A; Gajitsh M; Peco-Antitsh A; Krushchitsh D; Kostitsh M
Srp Arh Celok Lek; 1995; 123(11-12):291-4. PubMed ID: 16296241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
